Phase I trial of MEK 1/2 inhibitor pimasertib combined with mTOR inhibitor temsirolimus in patients with advanced solid tumors
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Aung Naing Razelle Kurzrock Siqing Fu Sarina Piha-Paul Filip Janku |
| Publication date | February 13, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |